Pharma major Lupin today announced the receipt of GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility (Unit II). The GMP Certificate was issued following an inspection conducted by PMDA between May 14, 2019 and May 17, 2019.
The PMDA inspection closed with no critical or major observations. The GMP Certificate issued by PMDA for Mandideep facility (Unit II) is valid till September 2024.
Shares of LUPIN LTD. was last trading in BSE at Rs.668.8 as compared to the previous close of Rs. 686.6. The total number of shares traded during the day was 154608 in over 4615 trades.
The stock hit an intraday high of Rs. 690 and intraday low of 646.2. The net turnover during the day was Rs. 103099859.